Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer

Cancer(2024)10.1002/cncr.35523Source: DataRank Database

Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer is a research paper published in Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.45)OA: bronzeTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Stephen Graves,Anusha Adkoli ORCID,Qin Zhou ORCID,Alexia Iasonos ORCID,Lora H. Ellenson ORCID

Live enrichment

PubMed:39150003 PMC:PMC11695162 OpenAlex:https://openalex.org/W4401646554

NIH HHS

Grant: P30 CA008748

NIH HHS

Grant: P50 CA247749

Cycle for Survival

Breast Cancer Research Foundation

FWCI

1.45

Citation Percentile

0.8%

Citation Trend

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.35523

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.35523

publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.35523

journalhttps://doi.org/10.1002/cncr.35523

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39150003

Fields of Study

PARP inhibition in cancer therapyBRCA gene mutations in cancerOvarian cancer diagnosis and treatment

MeSH Terms

Poly(ADP-ribose) Polymerase InhibitorsCarcinoma, Ovarian EpithelialAdultAgedFemaleGenetic TestingHumansMiddle AgedOvarian NeoplasmsBRCA1 ProteinBRCA2 ProteinGenomic InstabilityHomologous Recombination

Keywords

MedicineOvarian cancerSerous fluidBiopsyHistologyInternal medicineChemotherapyCancerUnivariate analysisOncologyPathologyMultivariate analysisMaintenance TherapyParp InhibitorHomologous Recombination Deficiency Testing

Sustainable Development Goals

SDG 0: Good health and well-being